Audifort Ingredients and Side Effects: What Every Ingredient Does (and Doesn’t Do)

Audifort’s ingredient panel covers the established antioxidant and nutritional pathways linked to cochlear function, with several ingredients at clinically relevant doses and a few at the lower end of studied ranges. The eight-ingredient formula combines a platelet-activating factor antagonist (Ginkgo Biloba), two mitochondrial antioxidants (NAC and Alpha Lipoic Acid), two micronutrients with cochlear-specific depletion patterns in tinnitus populations (Zinc and Magnesium), two B vitamins involved in auditory nerve function (B12 and B6), and a mitochondrial electron-chain cofactor (CoQ10). The safety profile is generally good at these doses for most healthy adults, with one critical exception: Ginkgo Biloba’s anticoagulant properties create real drug interaction risk that a meaningful fraction of supplement buyers will need to take seriously.

This analysis reviews each ingredient against published clinical dose ranges, explains the mechanism of action in plain language, characterizes the side effect profile, and identifies who should not take this formula without medical consultation.

---

TL;DR

• Eight-ingredient formula covering cochlear antioxidant protection, microcirculation, and nerve support pathways
• NAC (600 mg) and Alpha Lipoic Acid (200 mg) are at or within clinically studied ranges for auditory protection
• Ginkgo Biloba (120 mg) is at the low end of the clinical range — below the 240 mg dose used in trials showing positive tinnitus outcomes
• Magnesium (100 mg) is below the 167 mg used in the key RCT for noise-induced hearing loss prevention
• Critical safety note: Ginkgo Biloba interacts with anticoagulants, antiplatelets, and several antidepressants — anyone on these medications should consult a physician before using Audifort
• 60-day money-back guarantee provides a low-risk trial window

Check Current Pricing on the Official Website{rel=“nofollow sponsored”}

---

1. Overview of Audifort’s Formula

Audifort is marketed as a dietary supplement for supporting hearing health and managing tinnitus — the perception of ringing, buzzing, or hissing sounds in the absence of external stimulus. To understand what causes tinnitus and whether a supplement formula can address it, you have to start with cochlear biology.

The inner ear is metabolically one of the most oxygen-intensive tissues in the body. Cochlear hair cells depend on adequate blood flow through a single arterial supply — the labyrinthine artery — with no collateral circulation. This means any reduction in microcirculation, any oxidative stress event, or any deficiency in the mitochondrial energy supply has disproportionate consequences for hair cell function compared with other body tissues.

Audifort’s formula is built around this biology. The eight ingredients target four primary mechanisms:

1. Cochlear microcirculation — Ginkgo Biloba improves blood flow and inhibits platelet aggregation in small vessels
2. Oxidative stress protection — NAC, Alpha Lipoic Acid, and CoQ10 reduce reactive oxygen species and support glutathione recycling in hair cells
3. Micronutrient repletion — Zinc and Magnesium address two minerals depleted in tinnitus populations, with magnesium having the strongest RCT-supported mechanism (NMDA receptor antagonism, cochlear vasodilation)
4. Auditory nerve support — Methylcobalamin (B12) and Pyridoxine (B6) support myelin integrity and neurotransmitter synthesis in the auditory pathway

For a broader view of how supplement formulas target these mechanisms, see our educational overview of how tinnitus supplements work.

---

2. Full Ingredient Panel

Ingredient	Claimed Dose	Clinical Range	Notes
Ginkgo Biloba Extract (24% flavonoids)	120 mg	120–240 mg/day	Cochlear microcirculation; PAF antagonist; interacts with anticoagulants
N-Acetyl-L-Cysteine (NAC)	600 mg	400–1,200 mg/day	Precursor to glutathione; ototoxin protection in animal studies; generally well-tolerated
Alpha Lipoic Acid	200 mg	100–600 mg/day	Mitochondrial antioxidant; may recycle vitamins C and E; some evidence in diabetic auditory neuropathy
Zinc (as Zinc Citrate)	15 mg	10–40 mg/day	Cochlear zinc depletion linked to tinnitus severity; 40 mg/day UL for supplemental zinc
Magnesium (as Magnesium Citrate)	100 mg	167–400 mg/day	Cochlear vasodilator; NMDA antagonism; noise-induced hearing loss prevention (RCT evidence)
Vitamin B12 (as Methylcobalamin)	500 mcg	500–1,000 mcg/day	Deficiency associated with tinnitus in observational data; methylcobalamin preferred form for nerve function
Vitamin B6 (Pyridoxine HCl)	10 mg	1.3–100 mg/day	Neurotransmitter synthesis cofactor (GABA, dopamine, serotonin); B6 deficiency rare in developed nations
CoQ10 (Coenzyme Q10)	100 mg	100–300 mg/day	Mitochondrial electron chain; limited tinnitus-specific clinical data; antioxidant capacity

Overall assessment: The formula is well-constructed in terms of mechanism diversity. Five of the eight ingredients (NAC, ALA, Zinc, B12, CoQ10) are at doses within or at the lower bound of the clinically studied range. Two (Ginkgo Biloba and Magnesium) are below the doses used in the most relevant positive clinical trials, though not below plausible biological effect thresholds. B6 is present at a level well within the safe daily range but is unlikely to produce benefit in people without pre-existing deficiency.

For more detail on what this formula is designed to treat, see our Audifort review.

---

3. Ginkgo Biloba — Mechanism, Dose, Evidence

Mechanism: Ginkgo Biloba Extract standardized to 24% flavone glycosides and 6% terpene lactones — the EGb 761 specification — acts on cochlear blood flow through two primary pathways. First, it inhibits platelet-activating factor (PAF), reducing platelet aggregation and increasing blood fluidity in the microvascular bed of the inner ear. Second, its terpene lactone constituents (ginkgolides A, B, C and bilobalide) have free radical scavenging activity, reducing oxidative damage to cochlear endothelium. The combined effect is improved perfusion of the labyrinthine artery circulation — the only vascular supply to cochlear hair cells.

Dose assessment: Audifort provides 120 mg. This is at the lower bound of the clinical range for EGb 761. The evidence record matters here:

• The Drew & Davies 2001 BMJ trial — the largest ginkgo/tinnitus RCT ever conducted, with 1,121 patients — used 150 mg/day and found no significant difference from placebo over 12 weeks.
• The Morgenstern & Biermann 2002 trial showing statistically significant tinnitus improvement used 240 mg/day EGb 761.
• The 2013 Cochrane systematic review concluded there is no reliable evidence that ginkgo outperforms placebo for tinnitus overall.

Audifort’s 120 mg dose is below both the dose that failed to show benefit (150 mg) and the dose associated with positive outcomes (240 mg). Being honest: the ginkgo component is the weakest link in this formula from a dose-adequacy standpoint for tinnitus specifically. What the ingredient does offer at 120 mg is likely some degree of cochlear microcirculation support and antioxidant protection — but claims of meaningful tinnitus reduction at this dose are not well-supported by the trial evidence.

For a complete analysis of the ginkgo clinical record for tinnitus, including the Cochrane review and what the positive trials actually showed, see our dedicated Ginkgo Biloba for Tinnitus review.

Safety note: This ingredient is responsible for Audifort’s most significant drug interaction risk. See Section 12 for full details.

---

4. N-Acetyl-L-Cysteine (NAC) — Mechanism, Dose, Evidence

Mechanism: NAC is the rate-limiting precursor to glutathione, the most abundant endogenous antioxidant in cochlear tissue. Cochlear hair cells — particularly outer hair cells — are highly vulnerable to oxidative stress from noise trauma, ototoxic drugs (cisplatin, aminoglycoside antibiotics), and metabolic dysfunction. When glutathione is depleted, reactive oxygen species accumulate and hair cell apoptosis accelerates. NAC replenishes cysteine availability for glutathione synthesis, maintaining the cochlea’s intrinsic antioxidant defense system.

Dose assessment: Audifort provides 600 mg/day. This is squarely within the range used in clinical research:

• A Kopke et al. 2007 trial examining NAC for noise-induced hearing loss used doses in the 400–900 mg range.
• Animal studies demonstrating ototoxin protection have used NAC doses that translate to approximately 400–1,200 mg/day in human equivalents.
• The most relevant caveat: the clinical evidence for NAC is strongest in the context of preventing noise-induced or ototoxin-induced hearing loss, not reversing established chronic tinnitus. If your tinnitus is already present and stable, NAC’s mechanism is more protective than restorative.

At 600 mg, Audifort’s NAC component is at a dose that provides meaningful glutathione support and falls within the range studied for auditory protection. This is one of the better-dosed ingredients in the formula.

Side effects: NAC is generally well-tolerated. The most commonly reported side effects at doses of 600 mg/day or above are mild nausea and GI discomfort, particularly when taken on an empty stomach. Some users report a temporary sulfurous or egg-like odor from breath or urine — this is a metabolic byproduct of cysteine metabolism and is harmless. Taking NAC with food largely eliminates GI complaints.

---

5. Alpha Lipoic Acid — Mechanism, Dose, Evidence

Mechanism: Alpha Lipoic Acid (ALA) functions as a mitochondrial antioxidant with a unique property: it is both fat-soluble and water-soluble, allowing it to quench free radicals in both cellular compartments. ALA also regenerates vitamins C and E from their oxidized forms, amplifying the overall antioxidant network in cochlear tissue. An additional mechanism relevant to auditory health: ALA upregulates the activity of glutamate dehydrogenase and supports the mitochondrial electron transport chain in hair cells, maintaining energy production under oxidative stress conditions.

Dose assessment: Audifort provides 200 mg/day. The clinical range is broad (100–600 mg/day), and 200 mg is within the lower-middle of this range. The most relevant evidence for auditory applications:

• A Heman-Ackah et al. 2010 study examining antioxidant combinations for noise-induced hearing loss included ALA as a component ingredient.
• Evidence specifically for ALA in tinnitus is limited — the strongest clinical data for ALA’s auditory effects is in diabetic auditory neuropathy, where ALA at 600 mg/day has shown improvements in nerve conduction velocity.
• For tinnitus without diabetic neuropathy as a contributing mechanism, ALA’s contribution is primarily through mitochondrial antioxidant support rather than a condition-specific mechanism.

At 200 mg, the dose is biologically active but is not the high-end supplementation dose used in the best-powered diabetic neuropathy trials. The ingredient is appropriate for the formula and well-tolerated, but expectations should be calibrated to the available evidence.

Side effects: ALA is well-tolerated at doses under 600 mg/day. At higher doses (600+ mg), some users report insomnia (likely from mild stimulatory effects of mitochondrial activation), skin rash, and GI discomfort. At Audifort’s 200 mg dose, these effects are uncommon.

---

6. Zinc — Mechanism, Dose, Evidence

Mechanism: Zinc is the second most abundant trace mineral in the inner ear, and the cochlea contains one of the highest zinc concentrations of any tissue in the body. Zinc serves multiple functions in auditory physiology: it is a cofactor for over 300 enzymes, supports the structural integrity of auditory hair cell stereocilia, and plays a role in the neurotransmitter dynamics of the auditory brainstem. Critically, observational data consistently shows that people with chronic tinnitus have lower serum zinc levels than matched controls without tinnitus — a finding replicated across multiple studies in different populations.

The mechanism linking zinc depletion to tinnitus may involve NMDA receptor function: zinc normally inhibits NMDA receptor activity in the cochlear nucleus. Zinc deficiency may disinhibit these receptors, increasing excitatory activity in the central auditory pathway in a way that generates or amplifies tinnitus perception.

Dose assessment: Audifort provides 15 mg as Zinc Citrate. This is within the clinically relevant range:

• Arda et al. 2003 found that zinc supplementation (50 mg/day for two months) produced significant tinnitus improvement in patients with low serum zinc — particularly those over age 60.
• The RDA for zinc is 8 mg/day for women and 11 mg/day for men; the Tolerable Upper Intake Level for supplemental zinc is 40 mg/day.
• Audifort’s 15 mg dose is above the RDA and well within the safe range, though below the 50 mg/day used in the Arda et al. trial showing the strongest benefit.

The important nuance here: zinc supplementation for tinnitus appears most effective in people who are zinc-deficient. If your zinc status is already adequate, additional zinc is unlikely to improve tinnitus. For more information on assessing zinc status and its relationship to hearing, see our overview of zinc deficiency and ear health.

Side effects: Zinc Citrate at 15 mg/day is well-tolerated. Zinc’s GI side effects (nausea, metallic taste) are dose-dependent and primarily a concern at doses above 40 mg/day. Chronic high-dose zinc (above 40 mg/day) can also impair copper absorption, but Audifort’s 15 mg dose does not approach this threshold.

---

7. Magnesium — Mechanism, Dose, Evidence

Magnesium is the ingredient in Audifort with the strongest direct clinical evidence for hearing protection — and the one where the formula’s dose most clearly falls short of the best-powered trial.

Mechanism: Magnesium acts on the cochlea through two distinct pathways. First, it is a potent NMDA receptor antagonist in the cochlear nucleus. Excessive NMDA receptor activation by glutamate (excitotoxicity) is a key mechanism in noise-induced cochlear damage — hair cells are destroyed when glutamate floods the synapse during intense sound exposure. Magnesium blocks this pathway. Second, magnesium is a direct vasodilator in the cochlear microvasculature: it opposes calcium-mediated vasoconstriction, maintaining cochlear blood flow during metabolic stress.

Dose assessment: Audifort provides 100 mg of elemental magnesium from Magnesium Citrate. The key reference point:

• The landmark Attias et al. 1994 RCT demonstrated that 167 mg/day of elemental magnesium (as magnesium aspartate) significantly reduced noise-induced permanent threshold shift in military recruits exposed to high-intensity impulse noise. This is the highest-quality RCT-level evidence for any mineral in hearing protection.
• Audifort’s 100 mg is below the 167 mg used in this trial. It is not negligible — magnesium deficiency is common in Western diets (approximately 50% of Americans consume below the EAR), and any increment toward sufficiency provides biological value — but 100 mg is a subtherapeutic dose relative to the evidence for noise-induced hearing loss prevention.

For people with normal magnesium status, 100 mg will have marginal incremental effect. For those with dietary magnesium insufficiency, this dose may close part of the gap toward adequacy.

For a deep dive into the magnesium-tinnitus research including the Attias et al. trial methodology, see Magnesium for Tinnitus: What the Evidence Says.

Side effects: Magnesium Citrate is one of the better-absorbed and better-tolerated magnesium forms. The primary side effect at higher doses (350+ mg supplemental magnesium/day) is osmotic diarrhea — this is the basis of magnesium’s use as a laxative at pharmaceutical doses. At 100 mg, GI effects are uncommon but possible in sensitive individuals, particularly if taken on an empty stomach.

---

Experience Audifort for Yourself — 60-Day Money-Back Guarantee

Every Audifort order is protected by a full 60-day money-back guarantee. If you’re unsatisfied for any reason, you can request a complete refund within 60 days — no questions asked.

Check Current Pricing on the Official Website{rel=“nofollow sponsored”}

---

8. B Vitamins (B12 and B6) — Mechanism, Dose, Evidence

Vitamin B12 (Methylcobalamin, 500 mcg)

Mechanism: Vitamin B12 is essential for myelin synthesis and maintenance throughout the nervous system, including the auditory nerve (cranial nerve VIII). B12-deficient myelin has impaired electrical conduction velocity, which can manifest as auditory processing changes and, in some cases, tinnitus. The methylcobalamin form (as used in Audifort) is the neurologically active form — it crosses the blood-brain barrier more readily than cyanocobalamin and is the form that directly participates in methionine synthase activity for myelin synthesis.

Evidence: The observational link between B12 deficiency and tinnitus is consistent across multiple studies. A Shemesh et al. 1993 study found that 47% of tinnitus patients had B12 deficiency, versus a much lower prevalence in non-tinnitus controls. B12 supplementation in deficient patients showed improvements in tinnitus loudness and handicap scores. The important caveat: this benefit is most pronounced in people who are actually B12-deficient. B12 deficiency is common in certain populations — older adults, vegetarians and vegans, and people taking metformin or proton pump inhibitors — but Audifort’s 500 mcg dose would correct most mild-to-moderate deficiency states.

Audifort uses methylcobalamin at 500 mcg, which is at the lower end of the 500–1,000 mcg therapeutic range used in B12-related tinnitus research. The dose is appropriate and the form choice is better than the cyanocobalamin used in many cheaper formulations. For more background on the B vitamin/hearing connection, see our article on B Vitamins and Hearing Health.

Vitamin B6 (Pyridoxine HCl, 10 mg)

Mechanism: Vitamin B6 (as pyridoxine) is a cofactor in the synthesis of several neurotransmitters involved in auditory signal processing, including GABA (the primary inhibitory neurotransmitter in the auditory brainstem), dopamine, and serotonin. B6 also plays a role in homocysteine metabolism — elevated homocysteine is associated with increased cochlear oxidative stress and vascular disease.

Evidence and dose: B6 deficiency is uncommon in developed nations, and the evidence for B6 supplementation specifically improving tinnitus in people with adequate B6 status is weak. Audifort’s 10 mg dose is well within the safe daily range (the UL is 100 mg/day) and provides nutritional insurance against subclinical B6 insufficiency, but it is unlikely to produce tinnitus benefit in someone who is not deficient. This is a reasonable inclusion for completeness but should not be the reason someone chooses this formula.

---

9. CoQ10 — Mechanism, Dose, Evidence

Mechanism: Coenzyme Q10 functions as an electron carrier in the mitochondrial respiratory chain (Complex I through Complex III) and as a fat-soluble antioxidant in the inner mitochondrial membrane. Cochlear hair cells have among the highest mitochondrial density in the body due to their continuous high-energy signaling demands. CoQ10 supports this metabolic machinery and reduces mitochondrial reactive oxygen species production — a relevant mechanism given that noise-induced and age-related hair cell loss both involve mitochondrial dysfunction and ROS accumulation.

Dose assessment: Audifort provides 100 mg/day of CoQ10. This is at the lower bound of the commonly used clinical dosage range (100–300 mg/day). While there are studies examining CoQ10 in cardiovascular disease, neurodegenerative conditions, and migraine at this dose range, the tinnitus-specific clinical data for CoQ10 is limited:

• Salami et al. 2010 examined antioxidant combinations including CoQ10 for idiopathic sudden sensorineural hearing loss, showing some benefit — but as part of a combination rather than CoQ10 in isolation.
• Direct evidence for CoQ10 monotherapy in tinnitus is sparse. The ingredient’s inclusion in Audifort is mechanistically sound but evidence-limited for the specific tinnitus indication.

At 100 mg, CoQ10 is at a dose that has been shown to raise plasma CoQ10 levels meaningfully and provides antioxidant support in the cochlear mitochondrial environment. The dose is appropriate and safe, though the strength of evidence for tinnitus specifically is weaker than for NAC or Magnesium.

Side effects: CoQ10 is very well-tolerated. Reported side effects at doses of 100–300 mg/day are rare and typically mild: GI discomfort, insomnia (if taken late in the day due to mild energizing effects), and very rarely skin reactions. CoQ10 may modestly reduce the anticoagulant effect of warfarin — a minor interaction worth noting for patients on anticoagulation therapy, though this effect is not well-established in clinical trials and is a lesser concern than Ginkgo Biloba’s interaction with anticoagulants.

---

10. Audifort Side Effects: What to Expect

For most users: Audifort is well-tolerated at the recommended dosage. The majority of people taking this formula will experience no significant adverse effects. The eight ingredients have well-characterized safety profiles individually, and the doses used in Audifort are within the range where serious adverse events are uncommon.

Common mild effects (affecting a minority of users):

• GI upset (nausea, loose stools, mild cramping): Most likely attributable to Magnesium Citrate and/or NAC, particularly when taken on an empty stomach. Taking Audifort with food eliminates this in most cases. This is the most commonly reported side effect across all the ingredients in this formula.
• Headache: Ginkgo Biloba causes mild headache in a fraction of users, particularly early in use. This is typically transient (first 1–2 weeks) and resolves with continued use.
• Sulfurous odor: NAC metabolism produces cysteine metabolites that some users notice as a faint sulfurous smell in breath or urine. This is harmless and dose-dependent.
• GI adaptation: CoQ10 may cause mild GI discomfort during the initial period of use, particularly at doses above 200 mg. At Audifort’s 100 mg dose this is uncommon.

Less common effects:

• Skin reactions: Rare allergic reactions to ginkgo (contact dermatitis at higher exposures; urticarial reactions at supplemental doses) have been reported in sensitive individuals.
• Insomnia: Both ALA and CoQ10 can have mild stimulatory effects if taken late in the day. Taking Audifort in the morning mitigates this.
• Blood pressure effects: Magnesium is a mild vasodilator; at 100 mg this effect is clinically negligible but could theoretically potentiate antihypertensive medications in sensitive individuals.

What is not expected at Audifort’s doses:

• Liver toxicity: None of these ingredients at these doses are associated with hepatotoxicity in otherwise healthy adults.
• Kidney toxicity: No nephrotoxic concerns at these doses in people with normal renal function (note: zinc and magnesium doses would need to be discussed with a nephrologist in cases of significant renal impairment).
• Bleeding events: See Section 11 — this is a risk only in the context of drug interactions, not as a direct side effect of Audifort in people not on anticoagulants.

For a comprehensive review of the product including user experiences and verified purchase reports, see our Audifort Review 2026.

---

11. Who Should Not Take Audifort (Contraindications)

This section is important. Audifort is marketed as a general health supplement, but the Ginkgo Biloba content creates a specific contraindication profile that affects a substantial portion of adults who might consider this product.

Absolute or near-absolute contraindications (consult a physician first):

1. Anticoagulant therapy: People taking warfarin (Coumadin), heparin, direct oral anticoagulants (rivaroxaban, apixaban, dabigatran, edoxaban), or low-molecular-weight heparins. Ginkgo Biloba inhibits platelet-activating factor and has antiplatelet activity that meaningfully potentiates anticoagulant effects. This is not a theoretical risk — case reports of bleeding complications exist. The NCCIH explicitly advises against ginkgo use in people on blood thinners.

2. Antiplatelet therapy: People taking aspirin (at antiplatelet doses), clopidogrel (Plavix), ticagrelor, prasugrel, or NSAIDs regularly. The combination of ginkgo’s anticoagulant effect with antiplatelet therapy increases bleeding risk. NSAIDs taken occasionally for pain are a lesser concern than chronic antiplatelet therapy.

3. Epilepsy or seizure disorders: Ginkgo Biloba has rare but documented case reports of lowering seizure threshold. People with epilepsy, or those on anticonvulsant medications with narrow therapeutic indices, should not take Audifort without explicit guidance from their neurologist.

4. Pre-surgical period: Most surgical anesthesiologists and guidelines recommend stopping ginkgo-containing supplements 2 weeks before any scheduled surgery due to bleeding risk.

Significant precautions (discuss with a healthcare provider):

• MAO inhibitors and certain antidepressants: Ginkgo has potential interactions with MAOIs and may affect serotonin metabolism in ways that interact with SSRIs and SNRIs. While the evidence for this interaction is not as strong as the anticoagulant interaction, it warrants disclosure to a prescriber.
• Pregnancy and breastfeeding: The safety of Audifort’s formula in pregnancy has not been studied. Ginkgo Biloba’s platelet inhibition and NAC’s cysteine bioavailability create theoretical concerns in pregnancy. Audifort should not be taken during pregnancy or breastfeeding without medical supervision.
• Significant renal impairment: Zinc and magnesium excretion is impaired in kidney disease; supplementation should be guided by a nephrologist in people with CKD stage 3+.
• Diabetes: ALA at higher doses can reduce blood glucose levels and may potentiate hypoglycemic medication effects. At Audifort’s 200 mg ALA dose this is a minor concern, but people with diabetes on insulin or oral hypoglycemic agents should monitor blood glucose when starting the product.
• Children and adolescents under 18: Audifort is formulated for adult use. The safety profile in pediatric populations has not been established.

For more perspective on who this product is likely suited for versus who should skip it, see our Audifort scam or legit assessment and our comparison of Audifort vs Quietum Plus.

---

12. Ingredient Interactions

Understanding how Audifort’s ingredients interact with each other and with medications is essential context for anyone with a complex medical history.

Within-formula synergies (positive interactions)

NAC + Alpha Lipoic Acid: These two antioxidants work synergistically. ALA regenerates oxidized glutathione back to its active reduced form, while NAC provides the cysteine building block for new glutathione synthesis. Together, they maintain cochlear antioxidant capacity more effectively than either alone — an established pharmacological synergy supported by Bhagavan & Chopra 2006 among others.

Magnesium + NAC: Both independently protect against noise-induced cochlear damage through different mechanisms (NMDA antagonism vs. glutathione maintenance). Animal studies combining the two show additive hearing protection versus either agent alone.

B12 + B6: Both are involved in homocysteine metabolism; their co-presence addresses this pathway more completely than either alone. Elevated homocysteine is associated with cochlear vascular disease and oxidative stress.

With medications (negative interactions — consult your prescriber)

Ginkgo Biloba + anticoagulants/antiplatelets: The primary and most clinically significant interaction. Additive bleeding risk with warfarin, heparin, DOACs, aspirin, clopidogrel, and NSAIDs. Do not combine without medical supervision.

Ginkgo Biloba + antidepressants: Possible pharmacodynamic interaction with SSRIs and MAOIs. Ginkgo has been reported to potentiate serotonergic effects in some case reports.

Ginkgo Biloba + anticonvulsants: Ginkgo’s rare ability to lower seizure threshold may reduce the effectiveness of anticonvulsant medications in epilepsy management.

ALA + diabetes medications: ALA can potentiate insulin sensitivity and may augment the glucose-lowering effect of insulin or oral hypoglycemics. Blood glucose monitoring is appropriate when starting Audifort if on these medications.

Zinc + copper: High-dose zinc (above 40 mg/day) impairs copper absorption via metallothionein competition. Audifort’s 15 mg dose is well below this threshold and does not create a copper depletion risk for most users.

CoQ10 + warfarin: CoQ10 may modestly antagonize warfarin’s anticoagulant effect (opposite direction from Ginkgo Biloba’s interaction). The clinical significance is debated — but for someone on warfarin, both ingredients in this formula affect INR in opposite directions, making monitoring especially important.

---

Visit Audifort Official Website — Risk-Free with 60-Day Money-Back Guarantee

Audifort is backed by a full 60-day refund policy. If the formula doesn’t meet your expectations, you can request a complete refund within 60 days of purchase — no questions asked.

Try Audifort Risk-Free for 60 Days{rel=“nofollow sponsored”}

---

13. Frequently Asked Questions

What are the main ingredients in Audifort?

Audifort’s formula includes eight primary ingredients: Ginkgo Biloba Extract (120 mg, standardized to 24% flavonoids), N-Acetyl-L-Cysteine or NAC (600 mg), Alpha Lipoic Acid (200 mg), Zinc as Zinc Citrate (15 mg), Magnesium as Magnesium Citrate (100 mg), Vitamin B12 as Methylcobalamin (500 mcg), Vitamin B6 as Pyridoxine HCl (10 mg), and CoQ10 (100 mg). Each ingredient targets a different aspect of cochlear function — from antioxidant protection to microcirculation to nerve health. For a complete breakdown of how these ingredients are expected to work together, see our article on how tinnitus supplements work.

Does Audifort cause any side effects?

Most users tolerate Audifort well. The most commonly reported side effects from the individual ingredients include mild GI upset (nausea, loose stools) from NAC and Magnesium, particularly when taken on an empty stomach; headache from Ginkgo Biloba in a minority of users; and temporary sulfurous odor from NAC at higher doses. These effects are generally mild and resolve with continued use or by taking the supplement with food. Serious adverse events are uncommon at the doses used in Audifort’s formulation.

Who should not take Audifort?

People on anticoagulant medications (warfarin, heparin, direct oral anticoagulants), antiplatelet drugs (aspirin, clopidogrel, NSAIDs), or certain antidepressants should consult a healthcare provider before taking Audifort because of Ginkgo Biloba’s anticoagulant properties. Pregnant or breastfeeding women should avoid the product without medical supervision. People with epilepsy should be cautious — Ginkgo Biloba has rare reports of lowering seizure threshold.

Is the NAC dose in Audifort effective?

At 600 mg/day, Audifort’s NAC dose is within the range used in studies examining NAC for noise-induced hearing loss protection (400–1,200 mg/day). The most relevant clinical context is ototoxin and noise exposure protection rather than reversal of established tinnitus. For glutathione antioxidant support in the cochlea, a consistent daily dose of 600 mg is biologically reasonable and appropriate.

Is there enough Magnesium in Audifort to work?

The 100 mg of elemental magnesium from Magnesium Citrate in Audifort is below the 167 mg used in the Attias et al. 1994 noise-induced hearing loss RCT — the best-powered trial showing hearing protection. It represents a meaningful but modest contribution to magnesium intake. People with dietary magnesium insufficiency (a common situation in Western populations) may benefit from this amount; those with already-adequate magnesium status may see less marginal benefit from this dose alone. See our detailed analysis of Magnesium for Tinnitus: What the Evidence Says.

Is the Ginkgo Biloba dose in Audifort the clinical dose?

The honest answer is no — not for tinnitus specifically. Clinical trials for tinnitus have used EGb 761 at 120–240 mg/day. Audifort’s 120 mg is at the lowest end of this range. The dose that showed no benefit in the large Drew & Davies 2001 BMJ trial was 150 mg, while the Morgenstern & Biermann 2002 trial showing positive effects used 240 mg. Audifort’s 120 mg may provide some cochlear circulation support but is below the dose associated with the clearest positive tinnitus outcomes in trials that showed benefit. For the full evidence picture, see our Ginkgo Biloba for Tinnitus review.

Does Audifort contain any allergens?

Audifort’s declared formulation does not include major allergens (dairy, soy, gluten, nuts). However, the capsule shell material, excipients, and manufacturing facility cross-contamination should be verified on the current product label for those with specific allergies, as formulations can change over time.

How does Audifort compare to other tinnitus supplements on the market?

Audifort’s formula is competitive with the broader tinnitus supplement category. Its NAC dose (600 mg) and CoQ10 dose (100 mg) are stronger than many competing formulas. Its Ginkgo Biloba and Magnesium doses are below the strongest clinical evidence thresholds — a pattern common across most commercially available tinnitus supplements. For direct comparisons to specific alternatives, see our Audifort vs Quietum Plus comparison and our broader review of does Audifort really work.

Check Current Pricing on the Official Website{rel=“nofollow sponsored”}

---

Get Audifort Now — Risk-Free with 60-Day Money-Back Guarantee

Audifort ships with a full 60-day money-back guarantee. Every bottle. If you try it and see no benefit, you can request a complete refund. That’s a low-risk window to evaluate whether the formula makes a difference for you.

See Current Pricing on the Official Audifort Website{rel=“nofollow sponsored”}

---

14. Overall Safety Assessment

Summary by ingredient:

Ingredient	Dose vs. Clinical Range	Side Effect Risk	Drug Interaction Risk
Ginkgo Biloba (120 mg)	Below positive-trial dose	Low (headache, GI)	HIGH — anticoagulants, antiplatelets, MAOIs
NAC (600 mg)	Within clinical range	Low (GI, odor)	Low
Alpha Lipoic Acid (200 mg)	Within clinical range	Low	Low-moderate (diabetes meds)
Zinc Citrate (15 mg)	Below highest-efficacy trial dose	Very low	Very low
Magnesium Citrate (100 mg)	Below RCT-supported protective dose	Low (GI at higher doses)	Low-moderate (antihypertensives)
Methylcobalamin B12 (500 mcg)	Within clinical range	Negligible	Very low
Pyridoxine B6 (10 mg)	Within safe range	Negligible	Very low
CoQ10 (100 mg)	At lower bound of clinical range	Very low	Low (warfarin — minor)

Overall safety rating for healthy adults not on medications: Good. The formula is well-within established safety parameters for each ingredient. The combination of antioxidants does not create additive toxicity concerns.

Overall safety for people on medications: Conditional. The Ginkgo Biloba content requires disclosure to any prescriber managing anticoagulant or antiplatelet therapy, epilepsy, or psychiatric conditions. This is not a reason to avoid Audifort categorically — but it is a reason to have a brief conversation with your physician before starting it, particularly if you are on warfarin, aspirin therapy, clopidogrel, or antidepressants.

Mechanistic coherence: The formula is logically constructed around the established pathways linking oxidative stress, micronutrient depletion, and cochlear microcirculation to tinnitus pathophysiology. Audifort is not a random collection of trending ingredients — it is a focused formula addressing the biological mechanisms most consistently implicated in cochlear health by the peer-reviewed literature.

Dose honesty: Two ingredients (Ginkgo at 120 mg and Magnesium at 100 mg) are below the doses used in the most relevant positive clinical trials. For potential buyers evaluating Audifort as a serious cochlear health supplement, this is worth knowing. It does not mean these doses are ineffective — it means the evidence bar for the specific dose in this formula is less clearly established than for some alternative formulations. If dose adequacy for these two ingredients is a priority, supplementing separately with additional Magnesium Citrate (to bring total intake to 300–400 mg/day from all sources) and evaluating whether EGb 761 at 240 mg/day would be a better ginkgo option are reasonable considerations.

For a full assessment of Audifort’s effectiveness based on the research and verified user reports, read our complete Audifort review for 2026.

---

Join Thousands Supporting Their Hearing Health with Audifort — Risk-Free with 60-Day Money-Back Guarantee

Every Audifort order is backed by a 60-day money-back guarantee. Try it for two full months. If you’re not satisfied, contact the vendor for a complete refund.

Visit the Official Audifort Website{rel=“nofollow sponsored”}

---

These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure or prevent any disease.